ロード中...
Classification of PR-positive and PR-negative subtypes in ER-positive and HER2-negative breast cancers based on pathway scores
PURPOSE: PR loss in ER+/HER2- breast cancer indicates worse prognosis and insensitivity to anti-estrogen therapy, while the mechanisms of PR loss in ER+/HER2- breast cancer remain unrevealed. METHODS: In this study, ER+/PR+/HER2- and ER+/PR-/HER2- breast cancer cases from TCGA were used. 1387 pathwa...
保存先:
| 出版年: | BMC Med Res Methodol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2021
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8141178/ https://ncbi.nlm.nih.gov/pubmed/34022815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12874-021-01297-8 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|